We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Certara Inc (CERT) USD0.01

Sell:$16.56 Buy:$16.59 Change: $0.21 (1.29%)
NASDAQ:2.03%
Market closed |  Prices as at close on 26 April 2024 | Switch to live prices |
Sell:$16.56
Buy:$16.59
Change: $0.21 (1.29%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 26 April 2024 | Switch to live prices |
Sell:$16.56
Buy:$16.59
Change: $0.21 (1.29%)
Market closed |  Prices as at close on 26 April 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Certara, Inc. is a provider of biosimulation technology and solutions for using Model-Informed Drug Development in the global biopharmaceutical industry. It is focused on producing medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its customers include life sciences companies of all sizes along with contract research organizations, academic institutions, and global regulators. Its software and service are used by approximately 2,400 biopharmaceutical companies and academic institutions across 66 countries, including 38 of the top 40 biopharmaceutical companies. It has operations in the United States, Australia, Canada, China, France, Germany, India, Italy, Japan, Luxembourg, Netherlands, Philippines, Poland, Portugal, Spain, Switzerland, Egypt, and the United Kingdom.

Contact details

Address:
4 Radnor Corporate Center, Suite 350
RADNOR
19087
United States
Telephone:
+1 (609) 7167900
Website:
https://www.certara.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
CERT
ISIN:
US15687V1098
Market cap:
$2.64 billion
Shares in issue:
160.19 million
Sector:
Health Care Technology
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • William Feehery
    Chief Executive Officer, Director
  • John Gallagher
    Chief Financial Officer
  • Robert Aspbury
    President - Simcyp
  • Leif Pedersen
    President - Software
  • Patrick Smith
    President - Integrated Drug Development
  • Drayton Virkler
    President - Regulatory and Access
  • Nicolette Sherman
    Chief Human Resource Officer
  • Richard Traynor
    Senior Vice President, General Counsel, Secretary
  • M. Andrew Schemick
    Senior Vice President - Corporate Operations and Integration

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.